Abstract Search

ea0026p77 | Endocrine tumours and neoplasia | ECE2011

Could ^99mTc labeled long-acting agonist of GLP-1 (Exendin-4) scintigraphy be a new tool in the diagnostics of unknown focus of insulinoma ? preliminary results

Hubalewska-dydejczyk A H D , Pach D P , Sowa-Staszczak A S S , Jabrocka-Hybel A J H , Stefanska A S , Gilis-Januszewska A G J , Mikolajczak R M , Janota B J

Introduction: GLP-1 receptors have been fund on different types of neoplasm cells and density of these receptors appears to be more frequent in some of them. GLP-1 receptor scanning offers a new approach for successful localization of small or not detectable by other methods insulinomas and other cancers such as MTC, gastrinoma, pheochromocytoma, gastrinoma, etc.Aim of the study: The aim of study was to present first successful experiences with the...

0 shares

Endocrine Abstracts

Could ^99mTc labeled long-acting agonist of GLP-1 (Exendin-4) scintigraphy be a new tool in the diagnostics of unknown focus of insulinoma ? preliminary results

BiosciAbstracts

Endocrine Abstracts

Could 99mTc labeled long-acting agonist of GLP-1 (Exendin-4) scintigraphy be a new tool in the diagnostics of unknown focus of insulinoma ? preliminary results

BiosciAbstracts

Could ^99mTc labeled long-acting agonist of GLP-1 (Exendin-4) scintigraphy be a new tool in the diagnostics of unknown focus of insulinoma ? preliminary results